Transgene Sa Is A Clinical Stage Biotechnology Company Based In Illkirch Graffenstadenfrancespecializing In Cancer Immunotherapyfounded In 1979The Company Focuses On Developing Therapeutic Vaccines And Oncolytic Viruses To Address Unmet Needs In Oncologyit Operates As A Subsidiary Of Institut Merieux Sa And Has Additional Sites In Lyonthe Ukand Shanghai Transgene Utilizes Two Proprietary Technology Platformsmyvaca Which Creates Personalized Therapeutic Vaccines Tailored To A Patient S Tumor Specific Genetic Mutationsand Invir Ioa Can Oncolytic Virus Platform Designed To Selectively Target And Destroy Cancer Cells While Activating Immune Responsesthe Company S Clinical Stage Candidates Include Tg4050Targeting Hpv Positive Cancersand Several Oncolytic Viruses Aimed At Enhancing Anti Tumor Immune Activityunder The Leadership Of Ceo Philippe Archinardtransgene Collaborates With Academic And Industry Partners To Advance Its Innovative Pipeline In Cancer Treatment
No conferences found for this company.
| Company Name | Transgene Sa |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
